US Executive Compensation Proxy SEC Filings — July 07, 2026

07-07-2026

Lakeshore Acquisition III Corp. (LCCCR) filed a definitive proxy statement (DEF 14A) on July 7, 2026, for an Extraordinary General Meeting scheduled for July 27, 2026. The meeting seeks shareholder approval to extend the deadline to complete a business combination from August 1, 2026 to August 1, 2027, via a Charter Amendment and Trust Amendment, with monthly extension fees of up to $67,500. The company has already entered into a merger agreement with CPRO Electronics Holding Limited on May 22, 2026, but may not have sufficient time to close before the current deadline; if the extension is not approved and no business combination is completed by August 1, 2026, the company will liquidate and public shareholders will receive a pro-rata share of the trust account, which held approximately $72.1 million as of July 6, 2026, while founder shares and private placement units will become worthless.

• · The Extraordinary General Meeting will be held on July 27, 2026 at 10:00 a.m. Eastern Time, both in person at Loeb & Loeb LLP, 345 Park Avenue, New York, NY 10154, and virtually via Zoom.
• · The record date for voting is July 1, 2026.
• · Shareholders may redeem their Public Shares regardless of how they vote, and the redemption deadline is July 23, 2026 (two business days before the meeting).
• · If the extension is not approved and no business combination is completed by August 1, 2026, the company will cease operations, redeem Public Shares, and dissolve; the Rights will expire worthless.
• · The Charter Amendment and Trust Amendment are cross-conditioned on each other's approval.
• · The company expects significant redemptions at the Extraordinary General Meeting.

07-07-2026

Nextpower Inc. filed its definitive proxy statement (DEF 14A) on July 7, 2026, for the 2026 Annual Meeting of Stockholders to be held virtually on August 18, 2026. The meeting includes four proposals: election of four director nominees, ratification of Deloitte & Touche LLP as auditor for FY ending March 31, 2027, advisory approval of named executive officer compensation, and amendments to the certificate of incorporation to remove legacy Class B common stock provisions. As of the June 22, 2026 record date, 151,653,265 shares of Class A common stock were outstanding with no Class B shares outstanding, indicating a simplified capital structure.

• · Annual Meeting will be held virtually on August 18, 2026 at 8:00 a.m. Pacific Time via www.virtualshareholdermeeting.com/NXT2026
• · Record date for voting is June 22, 2026
• · No shares of Class B common stock were outstanding as of the record date
• · Proposal 4 seeks to remove legacy Class B common stock and other outdated provisions from the certificate of incorporation and rename Class A common stock
• · Proxy materials available online at www.proxyvote.com starting July 7, 2026

07-07-2026

Seneca Foods Corp filed its DEF 14A proxy statement for fiscal year 2026, detailing executive compensation and corporate governance. CEO Paul L. Palmby's total compensation increased 28.9% to $1,304,968, driven by a higher non-equity incentive plan payout ($402,291 vs $155,475 in FY2025). However, the company's median employee pay was $80,235, resulting in a CEO pay ratio of 16:1, and the company excluded 92 employees from the pay ratio calculation due to the March 2026 acquisition of the Green Giant U.S. frozen business.

• · The company exceeded the 7.40% ROIC bonus target for fiscal year 2026, resulting in a 50% bonus payout for named executive officers.
• · CEO Paul L. Palmby has 35 years of credited service under the Pension Plan, the maximum allowed, with a present value of accumulated benefit of $1,144,152.
• · CFO Michael S. Wolcott has only 8 years of credited service and a pension benefit of $27,905, significantly lower than other NEOs.
• · COO Timothy R. Nelson and SVP Dean E. Erstad each hold 980 shares of unvested restricted stock as of March 31, 2026, with a market value of $148,098 each.
• · CEO Paul L. Palmby has no outstanding equity awards as of March 31, 2026.
• · The company excluded 92 employees from the pay ratio calculation due to the March 2, 2026 acquisition of the Green Giant U.S. frozen business from B&G Goods Inc.
• · The annual limitation on earnings considered for pension benefits in 2026 is $360,000, and the maximum permitted annual retirement income is $290,000.

07-07-2026

CO2 Energy Transition Corp. is seeking stockholder approval at its July 21, 2026 Annual Meeting to extend the deadline to complete a business combination from July 22, 2026 to as late as June 22, 2027, via up to eleven monthly extensions. The company has already extended twice from the original May 22, 2026 deadline but still needs more time. If the extension proposals are not approved and no deal is completed, the company will redeem all public shares at approximately $10.54 per share and dissolve, while the stock closed at $10.44 on July 6, 2026, indicating a slight discount to the redemption value.

• · The company's original deadline to complete a business combination was May 22, 2026, and it has already extended twice to July 22, 2026.
• · If the extension proposals are not approved and no business combination is completed, the company will redeem 100% of Public Shares and dissolve, with rights expiring worthless.
• · The redemption price per share ($10.54) is slightly above the recent closing price ($10.44), suggesting a small arbitrage opportunity for public stockholders.
• · Approval of the Extension Amendment requires a majority of all outstanding shares; approval of the Trust Amendment requires at least 50% of Public Shares.
• · The Record Date for voting is July 7, 2026.

07-07-2026

Nuwellis, Inc. is seeking stockholder approval for two proposals: (1) the issuance of up to 2,396,709 shares of common stock upon exercise of warrants issued in a June 2026 financing that raised approximately $6.0 million in gross proceeds, and (2) an amendment to the certificate of incorporation to effect a reverse stock split at a ratio between 1-for-5 and 1-for-70, at the Board's discretion, to maintain Nasdaq listing compliance. While the company currently meets the minimum bid price requirement, it seeks the reverse split as a precautionary measure; failure to approve the warrant issuance could result in recurring costs and lost potential proceeds of up to $18.0 million from Series C warrant exercises.

• · The reverse stock split ratio range is 1-for-5 to 1-for-70, to be determined by the Board at its discretion within one year of stockholder approval.
• · The Series C Warrants contain a one-time price reset to the greater of 20% of the offering price or 90% of the lowest VWAP in the five trading days after a reverse stock split.
• · The Series D Warrants have a zero cash exercise option, allowing holders to receive shares without additional payment.
• · If Proposal 1 is not approved, the company must hold a stockholder meeting every 60 days until approval is obtained, incurring substantial costs.
• · The Board may abandon the reverse stock split if it determines it is not in the best interests of the company.
• · The company had 92,201 common shares outstanding as of June 5, 2026, with an additional 2,424,813 shares reserved for outstanding warrants.

07-07-2026

Interpace Biosciences, Inc. filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders scheduled for August 20, 2026. The filing seeks stockholder approval on seven proposals including an amended and restated certificate of incorporation, a reverse stock split (range 1-for-2 to 1-for-10), a new 2026 Equity Incentive Plan, a 2026 Employee Stock Purchase Plan, election of directors, a non-binding advisory vote on executive compensation, and ratification of EisnerAmper LLP as independent auditor. Two investors hold approximately 84% of outstanding common stock, giving them substantial control over all voting outcomes.

• · The Annual Meeting will be held virtually on August 20, 2026.
• · Record date for voting is June 29, 2026.
• · The reverse stock split proposed is within a range of 1-for-2 to 1-for-10, with exact ratio to be determined by the Board, and must be implemented within one year after stockholder approval.
• · Broker non-votes will occur on non-routine proposals (1, 3, 4, 5, 6) and will have no effect except on Proposal 1 where they have the same effect as a vote AGAINST.
• · Abstentions on Proposal 1 have the same effect as a vote AGAINST.
• · The mailing of the Notice of Internet Availability is scheduled to begin on or about July 10, 2026.
• · Thomas W. Burnell serves as President, CEO, and Chairman of the Board.

07-07-2026

Kewaunee Scientific Corporation filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Stockholders, to be held virtually on August 26, 2026. The meeting will include the election of three Class I directors (Thomas D. Hull III, David S. Rhind, and John D. Russell), ratification of Forvis Mazars, LLP as independent auditors for fiscal year 2027, and an advisory vote on named executive officer compensation. The filing does not include financial results or performance metrics, but the company is continuing its e-proxy process to reduce costs and environmental impact.

• · Annual Meeting will be held virtually on August 26, 2026 at 11:00 AM Eastern Time.
• · Record date for voting is June 29, 2026.
• · Stockholders can access proxy materials at www.proxyvote.com.
• · The company is mailing Notice of Internet Availability of Proxy Materials on or about July 7, 2026.
• · Three Class I director nominees are Thomas D. Hull III, David S. Rhind, and John D. Russell, each for a three-year term.
• · Forvis Mazars, LLP is proposed to be ratified as independent auditors for fiscal year 2027.
• · An advisory vote on named executive officer compensation is included.

07-07-2026

D. Boral ARC Acquisition I Corp. (BCAR) filed a definitive proxy statement (DEFM14A) for its business combination with Exascale Labs Inc., an AI infrastructure provider. The all-stock deal will issue 50,000,000 shares of PubCo common stock to Exascale securityholders, and the combined entity will be renamed 'Exascale Labs Holdings Inc.' and list on Nasdaq under 'XLAB' and 'XLABW'. However, the filing highlights significant dilution risk for public shareholders, with non-affiliated public ownership dropping from 30.7% to as low as 0% under a 100% maximum redemption scenario, and the combined company's new modular data center and energy solutions have not yet generated any revenue.

• · Exascale's modular data center, liquid cooling, HVDC power and energy storage solutions have not yet generated any revenue as of the proxy date.
• · The Business Combination Agreement was entered into on January 11, 2026.
• · BCAR's units, Class A ordinary shares and public warrants currently trade on Nasdaq under BCARU, BCAR and BCARW.
• · The combined company will be domiciled in Delaware after a domestication merger from the British Virgin Islands.
• · Exascale's core business is asset-light, software-defined GPU compute platform (GaaS) sourced from third-party data centers.
• · Under a 100% maximum redemption scenario, non-affiliated public shareholders would hold 0% of PubCo Class A shares and 0% voting power.
• · PubCo Class B Super Common Stock carries 20 votes per share vs. 1 vote per share for Class A, giving former Exascale stockholders 91-95% voting control.

07-07-2026

RCI Hospitality Holdings, Inc. filed a Definitive Proxy Statement (DEF 14A) on July 7, 2026, for its Annual Meeting of Stockholders scheduled for August 20, 2026. The meeting will include the election of six directors, ratification of CBIZ CPAs P.C. as independent auditor for fiscal year ending September 30, 2026, and a non-binding advisory vote on executive compensation. As of the record date of June 22, 2026, the company had 7,644,500 shares of common stock outstanding.

• · Annual Meeting will be held on August 20, 2026, at 10:00 a.m. Central Time at 10737 Cutten Road, Houston, Texas.
• · Record date for voting is June 22, 2026, with 7,644,500 shares of common stock outstanding.
• · Proxies will be voted FOR all six director nominees, FOR ratification of CBIZ CPAs P.C., and FOR approval of the non-binding advisory resolution on executive compensation.
• · Brokers have discretionary authority to vote on ratification of auditor (Proposal 2) but not on director elections (Proposal 1) or executive compensation (Proposal 3) without beneficial owner instructions.
• · Eric S. Langan has been a director since 1998 and served as President and CEO from 1999 until November 2025, when he became Head of Mergers & Acquisitions.